Sanara Ventures News
9 articles
טבע משקיעה 10 מיליון דולר בטכנולוגיה רפואית ישראלית
Teva Pharmaceutical Industries Ltd. has announced an investment of $10 million in Sanara Capital, a Health-Tech fund from the Sanara group. This investment aligns with Tevas commitment to innovation and supports its Pivot to Growth strategy. Sanara Capital is a venture capital fund that invests in Israeli startups in the fields of digital health, Bio-Convergence, and medical equipment. The fund was established two years ago and has so far invested in six companies.
Investment
Sanara sets up $100m VC fund to transform healthcare
Sanara Ventures, a healthcare investment platform backed by Teva Pharmaceutical Industries and Philips Healthcare, is setting up a $100 million venture capital fund to take advantage of opportunities in the healthcare sector caused by the Covid pandemic. The CEO of Sanara Ventures, Assaf Barnea, believes that changing the incentive model across the healthcare system, including technology companies, is key to solving its problems. Sanara Ventures is interested in investing in digital health, data-driven medical equipment, and bioconvergence companies. The fund has already made investments in TailorMed and CVAID Medical. Barnea also emphasizes the importance of cooperation and information sharing among market players in the healthcare sector.
Investment
Ichilov Hospital and Sanara Ventures to join forces to promote innovation in neurology
Ichilov Hospital and Sanara Ventures have partnered to collaborate in the field of neurology, with Sanara Ventures investing in the hospitals innovative technologies. The collaboration aims to turn ideas and projects developed in the neurology department into groundbreaking projects in the fields of digital health and neurology. Sanara Ventures will provide holistic and technological assistance to researchers and help guide startups throughout the investment stages. The partnership intends to support early-stage ventures, provide funding, and realize their business and technological potential. Sanara Ventures is an investment platform for innovative startups, backed by the Israeli Innovation Authority and including global giants such as Philips Healthcare and Teva Pharmaceuticals.
Partners
Israel is in a great position to capitalize on the rapid rise of medtech, says veteran investor
Assaf Barnea, CEO of Sanara Ventures, emphasizes the importance of knowledge-sharing and defining a product in the life science sector. Sanara Ventures, backed by Phillips and Teva Pharmaceutical Industries Ltd., supports 16 portfolio companies in the digital health and medical equipment sectors. The COVID-19 pandemic expedited innovation in medicine but also affected investments. Barnea highlights the shift towards telemedicine, remote diagnostics, patient engagement, and AI-powered decision support. Israel, with its numerous medical startups, is well-positioned to benefit from this breakthrough. The Israeli government has invested in digital health, and there is a vibrant investment community for Israeli medtech. Barnea encourages entrepreneurs to precisely define their business models and reduce burn rate. He also emphasizes the negative impact of canceled conferences on knowledge-sharing.
InvestmentPartners
https://www.jpost.com/health-science/necessity-is-the-mother-of-digital-healthcare-acceleration-625117
The coronavirus outbreak has accelerated the adoption of digital healthcare and telemedicine, causing a paradigm shift in the mindset of healthcare systems worldwide. Sanara Ventures, a healthcare investment platform, predicts that digital solutions will dramatically change the way care is delivered in the next two to five years globally. The company is seeking investments for its new Sanara Capital fund, which focuses on artificial intelligence-related solutions in medicine. The government of Israel has approved a national digital health plan to accelerate technological development, and approximately 580 digital health companies are operating in Israel. Sanara Ventures is building a catalog of Israeli companies offering solutions related to the crisis, ranging from ventilation machines to remote monitoring and disease management. The companys portfolio company, MyHomeDoc, is nearing US FDA approval for its digital health smartphone add-on that enables primary care tests for patients at home.
InvestmentExpand
Sanara Ventures Announces Winners of Healthcare Startup Competition
Sanara Ventures Ltd., an Israel-based healthcare-focused early stage investment group and incubator backed by Teva Pharmaceutical Industries Ltd. and Koninklijke Philips NV, has announced the winners of its startup competition. LuSeed Vascular Ltd. won the medical device category, while TuneFork won the digital health category. Both companies will receive a seed investment of up to $1 million each, as well as mentoring.
Investment
Sanara Ventures cements Teva-Philips ties
Sanara Ventures, an incubator launched by Teva and Philips, is filling the void in the medical devices sector by investing in early-stage companies. Sanara Ventures has already invested in four companies and is open to investing in foreign companies as well. The incubator focuses on digital medicine, telemedicine, drug delivery, simulation, microinvasive procedures, diagnostics, and technologies related to sickness and health. Sanara Ventures provides both financial support and professional guidance to help startups succeed. The incubator has a budget of NIS 100 million and plans to make 10 investments in 2016. Sanara Ventures aims to have a diversified portfolio and become a platform that supports ventures through the ups and downs.
InvestmentExpand
Sanara Ventures To Invest $26.5M In Israeli Health Tech
Teva Pharmaceutical Industries and Philips Healthcare will invest up to $26.5 million in Israeli medical device and health innovation startups through their joint fund, Sanara Ventures. Sanara Ventures has already invested in two Israeli companies, Kaleidoscope Medical and MGD. The fund was established this year and is headed by Assaf Barnea.
Investment
Teva, Philips Healthcare incubator begins operations
Sanara Ventures, a technological incubator of Teva Pharmaceutical Industries Ltd. and Philips Healthcare, has officially begun operations. Based in the Raanana high-tech industrial park, the incubator is designed for early-stage health-tech companies, and will provide funding and mentoring in a wide range of medical categories in medical devices, and medical technologies that complement drug development. Over the next 8 years, Teva and Philips Healthcare are committed to investing up to NIS 100 million in the incubators companies.
InvestmentPartners